PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

meaningless drift, page-48

  1. 592 Posts.
    lightbulb Created with Sketch. 65
    Sticking to timelines, and corporate transparency by making some announcements will hopefully create some demand. Although one would hope that the current sp despite dilution is fairly attractive. I bought a few more and I will be watching it very closely over the next few weeks. A great opportunity for long term investors or big pharma to show some interest.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.